← Leaderboards
Edward S. Mocarski
Stanford University
$11,996,025
Attributed
$11,996,025
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$18,501,382 · 14
By mechanism
R01$10,268,610 · 6
P01$6,726,805 · 3
R56$775,800 · 2
R21$706,167 · 2
R13$24,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Paul A Khavari$40,653,927
- Samuel Strober$36,157,957
- Li Ye$11,311,054
- Laura Simpson$111,360
- Marlene Rabinovitch$40,032,014
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusInfectionCellsCell TypeVirus DiseasesGene ExpressionMacrophageImmunePathway InteractionsVirusInsightTissuesApoptosisPathogenesisVirus Infection MechanismViralCytokineHost DefenseCell DeathTissue /Cell CultureCessation Of LifeMonocyteApoptoticMurid Herpesvirus 1
Grant awards (51)
Cytomegalovirus DNA Replication and Inversion$385,908
R01 · FY2021 · AI · contact PI
Cytomegalovirus DNA Replication and Inversion$386,280
R01 · FY2020 · AI · contact PI
3-D Culture Models$195,000
R21 · FY2020 · AI · contact PI
Cytomegalovirus DNA Replication and Inversion$386,618
R01 · FY2019 · AI · contact PI
3-D Culture Models$234,000
R21 · FY2019 · AI · contact PI
Innate activation and death signals in health and disease$390,000
R01 · FY2018 · AI · contact PI
Cytomegalovirus DNA Replication and Inversion$386,926
R01 · FY2018 · AI · contact PI
Innate activation and death signals in health and disease$390,000
R01 · FY2017 · AI · contact PI
Cytomegalovirus DNA Replication and Inversion$387,205
R01 · FY2017 · AI · contact PI
Innate activation and death signals in health and disease$574,409
R01 · FY2016 · AI · contact PI
Innate activation and death signals in health and disease$390,000
R01 · FY2015 · AI · contact PI
Cell Death Pathways in Cytomegalovirus Pathogenesis and Control$387,900
R56 · FY2014 · AI · contact PI
Benefits of Eliminating Cell Death Pathways in Health and Disease$296,400
R01 · FY2014 · GM · contact PI
Cytomegalovirus DNA replication and inversion$357,002
R01 · FY2013 · AI · contact PI
Immune modulation in cytomegalovirus infection$387,900
R56 · FY2012 · AI · contact PI
Cytomegalovirus DNA replication and inversion$379,789
R01 · FY2012 · AI · contact PI
Cytomegalovirus DNA replication and inversion$379,789
R01 · FY2011 · AI · contact PI
Cytomegalovirus Pathogenesis in Immunodeficiency$294,213
R01 · FY2011 · AI · contact PI
Cytomegalovirus Pathogenesis in Immunodeficiency$297,184
R01 · FY2010 · AI · contact PI
Cytomegalovirus Pathogenesis in Immunodeficiency$79,679
R01 · FY2008 · AI · contact PI
Cytomegalovirus Pathogenesis in Immunodeficiency$306,000
R01 · FY2007 · AI · contact PI
Cytomegalovirus DNA Replication and Recombination$290,143
R01 · FY2007 · AI · contact PI
Cytomegalovirus DNA Replication and Recombination$312,799
R01 · FY2006 · AI · contact PI
Cytomegalovirus DNA Replication and Recombination$1
R01 · FY2006 · AI · contact PI
Transplant Arteriosclerosis: Viral and Host Mechanism$1,352,159
P01 · FY2005 · AI
Cytomegalovirus DNA Replication and Recombination$320,316
R01 · FY2005 · AI
Cytomegalovirus Pathogenesis in Immunodeficiency$277,562
R01 · FY2005 · AI
Pathogen-Host Standoff: Persistent and Latent Infection$24,000
R13 · FY2005 · AI
Transplant Arteriosclerosis: Viral and Host Mechanism$1,344,029
P01 · FY2004 · AI
Cytomegalovirus DNA Replication and Recombination$317,303
R01 · FY2004 · AI
Cytomegalovirus Pathogenesis in Immunodeficiency$277,455
R01 · FY2004 · AI
Transplant Arteriosclerosis: Viral and Host Mechanism$1,316,615
P01 · FY2003 · AI
Cytomegalovirus DNA Replication and Recombination$314,386
R01 · FY2003 · AI
Cytomegalovirus Pathogenesis in Immunodeficiency$277,350
R01 · FY2003 · AI
CYTOMEGALOVIRUS GENE REGULATION IN IMMUNODEFICIENCY$251,510
R01 · FY2003 · AI
Transplant Arteriosclerosis: Viral and Host Mechanism$1,243,249
P01 · FY2002 · AI
CYTOMEGALOVIRUS GENE REGULATION IN IMMUNODEFICIENCY$245,981
R01 · FY2002 · AI
Cytomegalovirus Pathogenesis in Immunodeficiency$161,729
R01 · FY2002 · AI
Cytomegalovirus control--cell proliferation/inflammation$0
P01 · FY2002 · AI
LATENCY AND REACTIVATION OF CYTOMEGALOVIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2002 · CA
Transplant Arteriosclerosis: Viral and Host Mechanism$1,249,305
P01 · FY2001 · AI
Cytomegalovirus Pathogenesis in Immunodeficiency$277,167
R21 · FY2001 · AI
CYTOMEGALOVIRUS DNA REPLICATION AND RECOMBINATION$254,483
R01 · FY2001 · AI
CYTOMEGALOVIRUS GENE REGULATION IN IMMUNODEFICIENCY$240,612
R01 · FY2001 · AI
LATENCY AND REACTIVATION OF CYTOMEGALOVIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2001 · CA
Cytomegalovirus control--cell proliferation/inflammation$0
P01 · FY2001 · AI
CYTOMEGALOVIRUS DNA REPLICATION AND RECOMBINATION$247,743
R01 · FY2000 · AI
CYTOMEGALOVIRUS GENE REGULATION IN IMMUNODEFICIENCY$234,903
R01 · FY2000 · AI
LATENCY AND REACTIVATION OF CYTOMEGALOVIRUS AFTER BONE MARROW TRANSPLANTATION$221,448
P01 · FY2000 · CA
VIRAL AND CELLULAR GENE EXPRESSION DURING CMV INFECTION$176,932
R01 · FY2000 · AI
LATENCY AND REACTIVATION OF CYTOMEGALOVIRUS AFTER BONE MARROW TRANSPLANTATION$0
P01 · FY2000 · CA